Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB Cause Intervertebral disc protrusion? 233 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 233 reports of Intervertebral disc protrusion have been filed in association with INFLIXIMAB (Renflexis). This represents 0.2% of all adverse event reports for INFLIXIMAB.

233
Reports of Intervertebral disc protrusion with INFLIXIMAB
0.2%
of all INFLIXIMAB reports
0
Deaths
91
Hospitalizations

How Dangerous Is Intervertebral disc protrusion From INFLIXIMAB?

Of the 233 reports, 91 (39.1%) required hospitalization, and 1 (0.4%) were considered life-threatening.

Is Intervertebral disc protrusion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 233 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB Cause?

Off label use (34,801) Drug ineffective (33,738) Condition aggravated (16,616) Rheumatoid arthritis (16,251) Pain (15,061) Fatigue (13,473) Arthralgia (13,441) Infusion related reaction (12,946) Product use issue (12,752) Drug intolerance (11,173)

What Other Drugs Cause Intervertebral disc protrusion?

ADALIMUMAB (2,760) ETANERCEPT (751) METHOTREXATE (648) SODIUM OXYBATE (427) PREGABALIN (415) TOFACITINIB (393) UPADACITINIB (384) INTERFERON BETA-1A (295) PREDNISONE (285) SECUKINUMAB (268)

Which INFLIXIMAB Alternatives Have Lower Intervertebral disc protrusion Risk?

INFLIXIMAB vs INFLIXIMAB-ABDA INFLIXIMAB vs INFLIXIMAB-AXXQ INFLIXIMAB vs INFLIXIMAB-DYYB INFLIXIMAB vs INFLIXIMAB-QBTX INFLIXIMAB vs INFLIXIMAB, RECOMBINANT

Related Pages

INFLIXIMAB Full Profile All Intervertebral disc protrusion Reports All Drugs Causing Intervertebral disc protrusion INFLIXIMAB Demographics